Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation

Unlike malignancies of the nervous system, there have been no mutations identified in Merlin in breast cancer. As such, the role of the tumor suppressor, Merlin, has not been investigated in breast cancer. We assessed Merlin expression in breast cancer tissues by immunohistochemistry and by real-tim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morrow, K. Adam, Das, Shamik, Metge, Brandon J., Ye, Keqiang, Mulekar, Madhuri S., Tucker, J. Allan, Samant, Rajeev S., Shevde, Lalita A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2011
Assuntos:
Molecular Bases of Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3220570/
https://ncbi.nlm.nih.gov/pubmed/21965655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M111.250035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados